Ovarian hyperstimulation syndrome is a severe and potentially fatal ia
trogenic disease thar affects 2% of women subjected to pharmacological
induction Of ovulation. The newest data on the clinical picture, risk
factors, pathophysiology and management Of this disease, are reviewed
.